Is Fate Therapeutics, Inc. overvalued?

Fate Therapeutics, Inc. (FATE) — key valuation metrics and fundamentals.

No verdict

Price

$2.57

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$299.6M

Dividend yield

0.0%

Return on equity

-58.9%

Sector

Healthcare

Fair value compares FATE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks